MedTrace Logo

Oxytocin Via Intramuscular Injection and Intravenous Bolus or Infusion for Prevention of Postpartum Hemorrhage

NCT01914419 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4983

Last updated 2016-03-11

No results posted yet for this study

Summary

The study will evaluate whether prophylactic oxytocin administered in the third stage of labor via intravenous (IV) infusion or IV bolus reduces the rate of postpartum hemorrhage compared to intramuscular (IM) injection.

Conditions

  • Postpartum Hemorrhage

Interventions

DRUG

Oxytocin

Sponsors & Collaborators

  • El Galaa Teaching Hospital

    collaborator OTHER

  • University of Alexandria

    collaborator OTHER

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Beverly Winikoff, MD, MPH · Gynuity Health Projects

  • Rasha Dabash, MPH · Gynuity Health Projects

  • Ilana Dzuba, MHS · Gynuity Health Projects

  • Jill Durocher · Gynuity Health Projects

  • Dyanna Charles, MPH · Gynuity Health Projects

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01914419 on ClinicalTrials.gov